https://www.gosh.nhs.uk/news/launching-our-patient-safety-incident-reporting-plan-psirp/
Launching our Patient Safety Incident Reporting Plan (PSIRP)
20 Feb 2024, 4 p.m.
GOSH has launched its new Patient Safety Incident Reporting Plan (PSIRP).
This plan outlines how we as an organisation will look at patient safety incidents, what tools will be used to investigate and how it will share and embed learning into everyday work.
The plan's objective
PSIRP forms part of the national Patient Safety Incident Response Framework (PSIRF), introduced by NHS England, which removes the requirement that only incidents meeting the criteria of a “serious incident” are investigated.
There will be greater engagement with those affected by safety events, including patients, families and colleagues, ensuring that they are treated with compassion and able to be part of an investigation.
Shona Little, Head of Patient Safety explains:
"PSIRF is about moving away from the idea of blaming one person or finding a single cause of something going wrong. We know that our colleagues come into work every day to give amazing care to our patients.
"This will help us make sure that if something does go wrong we have a greater set of tools to learn and embed new safety measures, with a focus on also learning from all of the excellent practice and care which is delivered every day in GOSH."
Could adapting our sinks combat super bugs?
Discover how a Consultant Microbiologist at GOSH turned an innovative idea into a patented product that could revolutionise infection control in hospitals, schools, and airports – helping to stop superbugs like MRSA.
GOSH pilots AI tool to give clinicians more quality-time with patients
Patients and clinicians at GOSH have been taking part in the first NHS trial of a bespoke healthcare AI assistant, TORTUS, to help increase face-to-face time during appointments.
New hope to prevent blindness in children with rare genetic disease
A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialled by Clinicians at GOSH and University College London Great Ormond Street Institute of Child Health (UCL GOS ICH).